Suchergebnisse - "Sridhar, Srikala S"

PubPharm (224)

51

Recent Advances in the Management of Penile Cancer : A Contemporary Review of the Literature

enthalten in: Oncology and therapy | 2021

von Stecca, C. | Alt, M. | Jiang, D. | +4

52

Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma : Applying clinical trial findings to clinical practice

enthalten in: Cancer treatment reviews | 2021

von Grivas, P. | Agarwal, N. | Pal, S. | +6

53

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma

enthalten in: BJU international | 2021

von D'Andrea, D. | Matin, S. | Black, P. | +21

CommentIn: J Urol. 2022 Jun;207(6):1346-1348. - PMID 35319252

54

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

enthalten in: Nature medicine | 2021

von Powles, T. | Carroll, D. | Chowdhury, S. | +21

CommentIn: Nat Med. 2021 May;27(5):761-763. - PMID 33941920

55

Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer-Reply

enthalten in: JAMA oncology | 2021

von Sridhar, S. | Ding, K. | Parulekar, W.

CommentOn: JAMA Oncol. 2020 Nov 1;6(11):1751-1758. - PMID 32940628

56

Lack of Evidence Does Not Equal Lack of Benefit : Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer : In response to: Dirk Böhmer and Arne Grün. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer

enthalten in: Current oncology reports | 2021

von Jiang, D. | Chung, P. | Kulkarni, G. | +2

CommentOn: Curr Oncol Rep. 2021 Jan 20;23(2):18. - PMID 33471212

57

Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer

enthalten in: Current oncology reports | 2021

von Jiang, D. | Chung, P. | Kulkarni, G. | +2

58

Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer

enthalten in: Current oncology reports | 2021

von Jiang, D. | Chung, P. | Kulkarni, G. | +2

59

Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer

enthalten in: Current oncology reports | 2021

von Jiang, D. | Chung, P. | Kulkarni, G. | +2

60

Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer

enthalten in: European urology | 2021

von Jiang, D. | Fallah-Rad, N. | Lee, R. | +6